During the past decade, Ifakara Health Institute conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ifakara Health Institute" #1 sponsor was "Global Alliance for TB Drug Development" with 3 trials, followed by "Ifakara Health Institute" with 3 trials sponsored, "Michael Hoelscher" with 2 trials sponsored, "Swiss Tropical & Public Health Institute" with 2 trials sponsored and "LegoChem Biosciences, Inc" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ifakara Health Institute" #1 collaborator was "Ifakara Health Institute" with 4 trials as a collaborator, "Radboud University Medical Center" with 3 trials as a collaborator, "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 2 trials as a collaborator, "German Federal Ministry of Education and Research" with 2 trials as a collaborator and "Sequella, Inc." with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Ifakara Health Institute" are "Malaria" (4 trials), "Pulmonary Tuberculosis" (3 trials), "Plasmodium Falciparum" (2 trials), "Tuberculosis" (2 trials) and "Tuberculosis, Pulmonary" (2 trials). Many other conditions were trialed in "Ifakara Health Institute" in a lesser frequency.

Most popular intervention types in "Ifakara Health Institute" are "Drug" (9 trials), "Biological" (2 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bedaquiline, Delamanid, Moxifloxacin" (2 trials), "Moxifloxacin" (2 trials), "pyrazinamide" (2 trials), "Active ingredient" (1 trials) and "Army combat uniform" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ifakara Health Institute" are 11 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ifakara Health Institute". 1 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ifakara Health Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ifakara Health Institute, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".